Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Guilin Sanjin Of China Trades Well In IPO Try, First In China In 10 Months

This article was originally published in PharmAsia News

Executive Summary

China's Guilin Sanjin Pharmaceutical prompted such a response on the day of its initial public offering, the Shenzhen Stock Exchange suspended trading on the shares. Before the halt, the first trading in China since IPOs were suspended 10 months ago, Guilin Sanjin shares rose by 20 percent. Trading was suspended in the Guilin Sanjin IPO and another company for just 30 minutes under stock exchange rules. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC072138

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel